These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 2207297)
1. Species differences in the pharmacokinetics of recainam, a new anti-arrhythmic drug. Scatina JA; Kimmel HB; Weinstein V; Troy SM; Sisenwine SF; Cayen MN Biopharm Drug Dispos; 1990 Jul; 11(5):445-61. PubMed ID: 2207297 [TBL] [Abstract][Full Text] [Related]
2. Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans. Scatina JA; Wells DS; Kimmel HB; Kemper CJ; Sisenwine SF Drug Metab Dispos; 1990; 18(5):746-52. PubMed ID: 1981731 [TBL] [Abstract][Full Text] [Related]
3. Metabolic disposition and pharmacokinetics of pelrinone, a new cardiotonic drug, in laboratory animals and man. Scatina JA; Hicks DR; Kraml M; Cayen MN Eur J Drug Metab Pharmacokinet; 1990; 15(1):37-48. PubMed ID: 2384116 [TBL] [Abstract][Full Text] [Related]
4. The absolute bioavailability and dose proportionality of intravenous and oral dosage regimens of recainam. Troy SM; Cevallos WH; Conrad KA; Chiang ST; Latts JR J Clin Pharmacol; 1991 May; 31(5):433-9. PubMed ID: 2050828 [TBL] [Abstract][Full Text] [Related]
5. Cardiac electrophysiology of the antiarrhythmic agent recainam (Wy-42,362) in anesthetized dogs: relation to plasma and myocardial concentrations. Colatsky TJ; Bird LB; Knowles JA J Cardiovasc Pharmacol; 1988 Mar; 11(3):308-16. PubMed ID: 2452923 [TBL] [Abstract][Full Text] [Related]
6. Disposition of a new tetrahydrocarbazole analgesic drug in laboratory animals and man. Scatina JA; Hicks DR; Kraml M; Cayen MN Xenobiotica; 1989 Sep; 19(9):991-1002. PubMed ID: 2815839 [TBL] [Abstract][Full Text] [Related]
7. Effects of renal function on recainam pharmacokinetics and pharmacodynamics. Cheng JW; Charland SL; Goldfarb S; Spinler SA Clin Pharmacol Ther; 1995 May; 57(5):492-8. PubMed ID: 7768071 [TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic and pharmacokinetic evaluation of intravenous recainam in patients with frequent ventricular premature complexes and unsustained ventricular tachycardia. Anderson JL; Reddy CP; Myerburg RJ; Waxman HL; de Vane PJ Am J Cardiol; 1993 Mar; 71(8):686-94. PubMed ID: 8447266 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic studies of CP-74,667, a new quinolone, in laboratory animals. Girard D; Gootz TD; McGuirk PR Antimicrob Agents Chemother; 1992 Aug; 36(8):1671-6. PubMed ID: 1329625 [TBL] [Abstract][Full Text] [Related]
10. Disposition of a novel and potent alpha(v)beta3 antagonist in animals, and extrapolation to man. Prueksaritanont T; Fernandez-Metzler C; Meng Y; Barrish A; Halczenko W; Rodan SB; Hutchinson JH; Duggan ME; Lin JH Xenobiotica; 2004 Jan; 34(1):103-15. PubMed ID: 14742139 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of the cephalosporin SM-1652 in mice, rats, rabbits, dogs, and rhesus monkeys. Matsui H; Yano K; Okuda T Antimicrob Agents Chemother; 1982 Aug; 22(2):213-7. PubMed ID: 6927282 [TBL] [Abstract][Full Text] [Related]